These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8918417)

  • 1. Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolization.
    Vitola JV; Delbeke D; Meranze SG; Mazer MJ; Pinson CW
    Cancer; 1996 Nov; 78(10):2216-22. PubMed ID: 8918417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver.
    Vitola JV; Delbeke D; Sandler MP; Campbell MG; Powers TA; Wright JK; Chapman WC; Pinson CW
    Am J Surg; 1996 Jan; 171(1):21-6. PubMed ID: 8554144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staging recurrent metastatic colorectal carcinoma with PET.
    Delbeke D; Vitola JV; Sandler MP; Arildsen RC; Powers TA; Wright JK; Chapman WC; Pinson CW
    J Nucl Med; 1997 Aug; 38(8):1196-201. PubMed ID: 9255148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.
    Rose DM; Delbeke D; Beauchamp RD; Chapman WC; Sandler MP; Sharp KW; Richards WO; Wright JK; Frexes ME; Pinson CW; Leach SD
    Ann Surg; 1999 May; 229(5):729-37; discussion 737-8. PubMed ID: 10235532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil.
    Findlay M; Young H; Cunningham D; Iveson A; Cronin B; Hickish T; Pratt B; Husband J; Flower M; Ott R
    J Clin Oncol; 1996 Mar; 14(3):700-8. PubMed ID: 8622014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy.
    Torizuka T; Tamaki N; Inokuma T; Magata Y; Yonekura Y; Tanaka A; Yamaoka Y; Yamamoto K; Konishi J
    J Nucl Med; 1994 Dec; 35(12):1965-9. PubMed ID: 7989978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer.
    Feine U; Lietzenmayer R; Hanke JP; Held J; Wöhrle H; Müller-Schauenburg W
    J Nucl Med; 1996 Sep; 37(9):1468-72. PubMed ID: 8790195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dual-time point images of the liver with (18)F-FDG PET/CT in suspected recurrence from colorectal cancer].
    Fuster D; Lafuente S; Setoain X; Navales I; Perissinotti A; Pavia J; Paredes P; Lomeña F; Pons F
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):111-6. PubMed ID: 22154291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the effect of treatment in patients with liver tumors using 18F-fluorodeoxyglucose PET].
    Okazumi S; Enomoto K; Ozaki M; Yamamoto H; Yoshida M; Abe Y; Takayama W; Yamada S; Isono K; Imazeki K
    Kaku Igaku; 1989 Jun; 26(6):793-7. PubMed ID: 2796006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the blood supply and efficacy of transcatheter arterial chemoembolization for patients with liver metastasis using
    Wang ZF; Fan XX; Xu M; Chen MJ; Zhao ZW; Zhou JD; Tu JF; Song JJ; Hu XH; Lu CY; Wu FZ; Zhang DK; Chen L; Liu L; Ying XH; Xu XF; Ji JS
    Tumour Biol; 2017 May; 39(5):1010428317701656. PubMed ID: 28475013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approach to clinical evaluation of cancer chemotherapy using positron emission tomography with 18FDG (2-deoxy-2-[18F]fluoro-D-glucose).
    Takahashi H; Yamaguchi K; Wakui A; Maeda S; Yang PK; Ito M; Matsuzawa T; Fukuda H; Ido T
    Sci Rep Res Inst Tohoku Univ Med; 1986 Dec; 33(1-4):38-43. PubMed ID: 3498212
    [No Abstract]   [Full Text] [Related]  

  • 12. Monitoring liver tumor therapy with [18F]FDG positron emission tomography.
    Nagata Y; Yamamoto K; Hiraoka M; Abe M; Takahashi M; Akuta K; Nishimura Y; Jo S; Masunaga S; Kubo S
    J Comput Assist Tomogr; 1990; 14(3):370-4. PubMed ID: 2335602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of several SUV-based parameters derived from 18F-FDG PET for prediction of survival after SIRT of hepatic metastases from colorectal cancer.
    Fendler WP; Philippe Tiega DB; Ilhan H; Paprottka PM; Heinemann V; Jakobs TF; Bartenstein P; Hacker M; Haug AR
    J Nucl Med; 2013 Aug; 54(8):1202-8. PubMed ID: 23729697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings.
    Frank A; Lefkowitz D; Jaeger S; Gobar L; Sunderland J; Gupta N; Scott W; Mailliard J; Lynch H; Bishop J
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1495-512. PubMed ID: 7635795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging metastatic testicular germ cell tumours with 18FDG positron emission tomography: prospects for detection and management.
    Wilson CB; Young HE; Ott RJ; Flower MA; Cronin BF; Pratt BE; McCready VR; Horwich A
    Eur J Nucl Med; 1995 Jun; 22(6):508-13. PubMed ID: 7556294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental study on the effectiveness of PET tumor images for cancer diagnosis].
    Yoshioka T; Takahashi H; Oikawa H; Kanamaru R
    Gan To Kagaku Ryoho; 1994 Feb; 21(3):369-73. PubMed ID: 8109993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.
    Abdel-Nabi H; Doerr RJ; Lamonica DM; Cronin VR; Galantowicz PJ; Carbone GM; Spaulding MB
    Radiology; 1998 Mar; 206(3):755-60. PubMed ID: 9494497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of local control after laser-induced thermotherapy of liver metastases from colorectal cancer: contribution of FDG-PET in patients with clinical suspicion of progressive disease.
    Denecke T; Steffen I; Hildebrandt B; Rühl R; Streitparth F; Lehmkuhl L; Langrehr J; Ricke J; Amthauer H; Hänninen EL
    Acta Radiol; 2007 Oct; 48(8):821-30. PubMed ID: 17924212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of PET-18FDG imaging in the clinical evaluation of head and neck lymphoma.
    Walsh RM; Wong WL; Chevretton EB; Beaney RP
    Clin Oncol (R Coll Radiol); 1996; 8(1):51-4. PubMed ID: 8688363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18FDG PET/CT imaging of schwannoma mimicking colorectal cancer metastasis.
    Ortega-Candil A; Rodríguez-Rey C; Cabrera-Martín MN; García García-Esquinas M; Lapeña-Gutiérrez L; Carreras-Delgado JL
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):332-3. PubMed ID: 23434018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.